Publications by authors named "Shin-ichiro Hashimoto"

Claim this Profile
A
Acute kidney injury after pegylated granulocyte colony-stimulating factor and dexamethasone.
Osamu Imataki, Shunsuke Yoshida, Shin-Ichiro Hashimoto, Makiko Uemura

Support Care Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Status and prognostic value of immunological biomarkers of breast cancer.
Chisa Murazawa, Nozomi Hashimoto, Kana Kuraishi, Mutsumi Motoyama, Shin-Ichiro Hashimoto

Oncol Lett· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Candidate biomarkers predictive of anthracycline and taxane efficacy against breast cancer.
Shoko Norimura, Keiichi Kontani, Takako Kubo, Shin-Ichiro Hashimoto, Chisa Murazawa

J Cancer Res Ther· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indication of metronomic chemotherapy for metastatic breast cancer: Clinical outcomes and responsive subtypes.
Keiichi Kontani, Shin-Ichiro Hashimoto, Chisa Murazawa, Shoko Norimura, Hiroaki Tanaka

Mol Clin Oncol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors responsible for long-term survival in metastatic breast cancer.
Keiichi Kontani, Shin-ichiro Hashimoto, Chisa Murazawa, Shoko Norimura, Hiroaki Tanaka

World J Surg Oncol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metronomic chemotherapy for metastatic breast cancer to prolong time to treatment failure to 12 months or more.
Keiichi Kontani, Shin-Ichiro Hashimoto, Chisa Murazawa, Shoko Norimura, Hiroaki Tanaka

Mol Clin Oncol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical usefulness of human epidermal growth factor receptor-2 extracellular domain as a biomarker for monitoring cancer status and predicting the therapeutic efficacy in breast cancer.
Keiichi Kontani, Noriyuki Kuroda, Shin-ichiro Hashimoto, Chisa Murazawa, Shoko Norimura

Cancer Biol Ther· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arteriosclerotic changes as background factors in patients with peripheral vestibular disorders.
Masaoki Wada, Hideaki Naganuma, Koji Tokumasu, Shin-ichiro Hashimoto, Akihiko Ito

Int Tinnitus J· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis